Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Psychosurgery

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...

Psychotherapy

Psychotherapy

Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Welcome to <i>Biochemistry</i> Volume 1: No Hyphen Required.

Biochemistry·2021

Same author

Erratum: Author Correction: High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity.

Communications biology·2019

Same author

High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity.

Communications biology·2019

Same author

Chemoproteomics Using Nucleotide Acyl Phosphates Reveals an ATP Binding Site at the Dimer Interface of Procaspase-6.

Biochemistry·2019

Same author

Correction: Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics.

PloS one·2017

Same author

ERK5 kinase activity is dispensable for cellular immune response and proliferation.

Proceedings of the National Academy of Sciences of the United States of America·2016

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

New LSD therapies unfolding.

John W Kozarich¹

¹ActivX Biosciences, Incorporated, 11025 North Torrey Pines Road, La Jolla, CA 92037, USA. johnk@activx.com

Chemistry & Biology

|September 22, 2007

Summary

NIH researchers conducted a high-throughput screening to identify novel chemical chaperones for treating Gaucher disease. This discovery offers a promising avenue for developing new therapies for this rare genetic disorder.

Area of Science:

Biochemistry
Genetics
Pharmacology

Background:

Gaucher disease is a lysosomal storage disorder caused by mutations in the GBA1 gene.
Enzyme replacement therapy is the current standard treatment, but chemical chaperones offer a potential alternative.
Chemical chaperones aim to stabilize the misfolded glucocerebrosidase enzyme, improving its function.

Purpose of the Study:

To identify novel small molecules that act as chemical chaperones for the glucocerebrosidase enzyme.
To find potential therapeutic agents for Gaucher disease using a quantitative high-throughput screening (qHTS) approach.

Main Methods:

Utilized a quantitative high-throughput screening (qHTS) assay to screen a large chemical library.
Assessed compounds for their ability to enhance the activity of a mutated form of glucocerebrosidase.

More Related Videos

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Related Experiment Videos

Last Updated: Jul 11, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Validated hit compounds through secondary assays to confirm chaperone activity and specificity.

Main Results:

Identified several novel chemical entities with significant chaperone activity.
Demonstrated that these compounds can improve the stability and catalytic function of the mutated glucocerebrosidase enzyme.
The screening yielded promising lead compounds for further drug development.

Conclusions:

The qHTS approach successfully identified novel chemical chaperones for Gaucher disease.
These compounds represent potential therapeutic candidates for Gaucher disease treatment.
Further preclinical development is warranted to assess the efficacy and safety of these novel chaperones.